0000950103-24-000410.txt : 20240108
0000950103-24-000410.hdr.sgml : 20240108
20240108160312
ACCESSION NUMBER: 0000950103-24-000410
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240104
FILED AS OF DATE: 20240108
DATE AS OF CHANGE: 20240108
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Antoniazzi Gilberto
CENTRAL INDEX KEY: 0001752661
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38694
FILM NUMBER: 24520031
MAIL ADDRESS:
STREET 1: LIVENT CORPORATION, C/O FMC CORPORATION
STREET 2: 2929 WALNUT STREET
CITY: PHILADELPHIA
STATE: PA
ZIP: 19104
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Livent Corp.
CENTRAL INDEX KEY: 0001742924
STANDARD INDUSTRIAL CLASSIFICATION: CHEMICALS & ALLIED PRODUCTS [2800]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 824688610
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1818 MARKET STREET
CITY: PHILADELPHIA
STATE: PA
ZIP: 19103
BUSINESS PHONE: 215-299-5900
MAIL ADDRESS:
STREET 1: 1818 MARKET STREET
CITY: PHILADELPHIA
STATE: PA
ZIP: 19103
FORMER COMPANY:
FORMER CONFORMED NAME: FMC Lithium USA Holding Corp.
DATE OF NAME CHANGE: 20180606
4
1
dp204998_4-antoniazzi.xml
FORM 4
X0508
4
2024-01-04
1
0001742924
Livent Corp.
LTHM
0001752661
Antoniazzi Gilberto
C/O LIVENT CORPORATION
1818 MARKET STREET, SUITE 2550
PHILADELPHIA
PA
19103
0
1
0
0
Vice President and CFO
0
Common Stock
2024-01-04
4
D
0
77991
D
0
D
Stock Option (Right to Buy)
23.33
2024-01-04
4
D
0
14914
D
2026-02-22
2033-02-22
Common Stock
14914
0
D
Stock Option (Right to Buy)
21.01
2024-01-04
4
D
0
16049
D
2025-02-23
2032-02-23
Common Stock
16049
0
D
Stock Option (Right to Buy)
20.35
2024-01-04
4
D
0
53328
D
2024-02-22
2031-02-22
Common Stock
53328
0
D
Represents the conversion of common stock and restricted stock units ("Livent RSUs") with respect to shares of common stock of Livent Corporation ("Livent"), par value $0.001 per share ("Livent Common Stock"), held by the reporting person as of January 4, 2024, into ordinary shares and restricted stock units with respect to ordinary shares of Arcadium Lithium plc ("Arcadium"), par value $1.00 per share ("Arcadium Ordinary Shares"), in accordance with the terms of the Transaction Agreement, dated as of May 10, 2023, by and between Livent, Allkem Limited ("Allkem"), Lightning-A Merger Sub, Inc. and Arcadium, providing for a combination of Livent and Allkem in a merger of equals transaction.
Represents the conversion of stock options to purchase Livent Common Stock ("Livent Options") into stock options to purchase Arcadium Ordinary Shares ("Arcadium Options"), in accordance with the terms of the Transaction Agreement, in connection with the merger of equals transaction.
/s/ Sara Ponessa, as Attorney-in-Fact
2024-01-08